Shiladitya Sengupta

Dr. Shiladitya Sengupta is a Venture Partner at Navam Capital Pvt Ltd., an Associate Professor at Harvard Medical School, a Director-Center for Engineered Therapeutics at Brigham & Womens Hospital and a Co-Founder at Mitra Biotech Pvt Ltd. He is on the Board of Directors at Vyome Holdings, Inc., Alyssum Therapeutics, Inc., Vyome Therapeutics, Inc., Akamara Biomedicine Pvt Ltd. and Vyome Therapeutics Pvt Ltd. Dr. Sengupta was previously employed as a Founder by Cerulean Pharma, Inc., a Co-Founder by Farcast Biosciences, Inc., and a Chairman-Regenerative Therapeutics Centre by The Brigham & Women's Hospital, Inc. He received his undergraduate degree from All India Institute of Medical Sciences and a doctorate degree from Trinity College, Cambridge.